An assembly for a medicament delivery device is presented where the medicament delivery device is arranged within a package as a first subassembly extending along a longitudinal axis from a first end to a second end and a second subassembly, where the package has a first shell with a first body that extends along the longitudinal axis and defines a first chamber inside the first body that holds the first subassembly. A second shell having a second body extends along the longitudinal axis and defines a second chamber that holds the second subassembly, where the second shell is attached to the first shell by a first hinge. The first shell has a first pulling element extending along the longitudinal axis and is attached to the first subassembly and is attached to the first body by a second, where the first pulling element has a first gripper arranged at a second end of the first pulling element.

A fat conditioning apparatus includes a conditioning vessel enclosing a conditioning chamber and a displacable plug. The conditioning chamber is bounded on one end by the displacable plug and has a variable volume that is a function of the position of the plug within the conditioning vessel. The apparatus has utility in a fat conditioning method, wherein the conditioning chamber contains a harvested fat emulsion. A washing liquid is injected into the conditioning chamber and mixes with the harvested fat emulsion, thereby displacing the plug in an outward expansion direction and expanding the variable volume of the conditioning chamber. The resulting mixture of harvested fat emulsion and washing liquid is stratified in the conditioning chamber into a contaminant-lean fat fraction and a contaminant-rich remainder fraction. The fat fraction, which is substantially free of the remainder fraction, is recovered from the conditioning chamber as a desired product of the method.

Polymeric compositions, methods, and delivery devices for inhibiting bleeding are disclosed. The method includes applying a dried material topically to a wound site, where the material may include a cross-linked biologically compatible polymer which forms a hydrogel when exposed to blood and where the material may not include an active agent such as thrombin. A spring-loaded delivery device as described herein may be used to apply the dried material.

A syringe holder for facilitating dispensing of medication to a patient from a syringe. The syringe holder includes a cylindrical housing configured to be attached to a barrel portion of the syringe. A first visual dosing aid on a surface of the cylindrical housing is of a first color and has a plurality of first dosing segments where the first color is correlated to a first patient size. Each of the first dosing segments identifies a volume of the medication corresponding to a first medication dose. A second visual dosing aid on a surface of the cylindrical housing is of a second color and has a plurality of second dosing segments where the second color is correlated to a second patient size. Each of the second dosing segments identifies a volume of the medication corresponding to a second medication dose.

The present invention relates to a monitoring device (10) arranged to be operably connected to a medicament delivery device (12), said medicament delivery device (12) comprising a manually operated movable dose activation element (20), said monitoring device (10) comprising an electronic circuit (42), said electronic circuit (42) comprising an optical sensor (68), wherein said optical sensor (68) is positioned in relation to said dose activation element (20) so as to detect a manual operation of said dose activation element (20) from an initial position; said electronics circuit further comprising a vibration sensor (70), wherein said vibration sensor (70) is positioned in relation to said medicament delivery device so as to detect specific vibration spectra produced by the medicament delivery device when said dose activating element (20) is operated, wherein said electronic circuit (42) comprises computing elements capable of correlating the information from the optical sensor (68) with the information from the vibration sensor (70) when said dose activation element (20) is operated in order to register when a correct dose has been set.

The present disclosure provides a modular, connectable, dual chamber syringe system that can be used to mix, dispense and/or inject multiple materials sequentially or concurrently. The dual chamber syringe system may be prefilled in advance with different materials, e.g., multiple medicaments, and prepackaged, and is capable of being removed from the packaging and being used immediately, such as in a medical setting. In one illustrative embodiment, the dual chamber syringe system includes a design with the following arrangement of the main components: hypodermic needle—first container with female threaded end—male threaded cap—female threaded cap—second container with male threaded end—plunger. In a second illustrative embodiment, the dual chamber syringe system includes a design with the following arrangement of the main components: hypodermic needle—first container with female threaded end—membrane—membrane—second container with male threaded end—plunger.

A wearable drug delivery device that can deliver a liquid drug stored in a container to a patient is provided. The container can be a prefilled cartridge that can be loaded into the drug delivery device by the patient or that can be preloaded within the drug delivery device when provided to the patient. A sealed end of the container is pierced to couple the stored liquid drug to a needle conduit that is coupled to a needle insertion component that provides access to the patient. A drive system of the drug delivery device can expel the liquid drug from the cartridge to the patient through the needle conduit. The drive system can be controlled to provide the liquid drug to the patient in a single dose or over multiple doses.

Provided herein is a housing assembly for a drug delivery device, including a first housing part having a first proximal end comprising a first engagement portion and a second engagement portion, a first distal end, and a first sidewall therebetween defining a first longitudinal axis and a first interior, the first sidewall comprising one or more windows therethrough; and a second housing part having a second proximal end, a second distal end comprising a third engagement portion and a fourth engagement portion, and a second sidewall therebetween defining a second longitudinal axis and a second interior.

An example syringe includes a barrel having a distal end region and an inner surface defining a lumen extending therein, wherein the inner surface includes a proximally facing surface, and wherein the distal end region includes a distal end. The syringe also includes a plunger having a body portion and a distal tip extending distally away from a distal end region of the body portion, wherein the distal end region includes a distally facing surface. Further, the plunger is configured to be positioned within the lumen of the barrel and a portion of the distal tip of the plunger extends distally of the distal end of the barrel when the plunger is positioned within the lumen of the barrel.

The present invention relates to a syringe, and more particularly, to an apparatus obtained by improving a conventional syringe formed with an injection flow passage including an injection needle, so as to share a portion of the injection flow passage except the injection needle or to form a suction flow passage completely independent of the injection flow passage, thereby further smoothing suction of a liquid medicine. The syringe is configured such that the separate suction flow passage bypassing the injection needle is formed in the conventional syringe to more smoothly perform suction of the liquid medicine, thereby maximizing user's convenience and marketability of the conventional syringe, and further configured to forcibly close the suction flow passage upon injection of the liquid medicine.